Transcode Therapeutics
Price & Volume
Stats
See more52W Range | $1.50-$12.60 |
Market Cap | $26.5M |
Shares Short | 54,968 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$52.06 |
News
See moreYahoo Finance • 2 months ago
Join Today's Live Investor Webinar with TransCode Therapeutics
Yahoo Finance • 4 months ago
Top Biotech Gainers: VRAX Jumps 100% After Fosun Deal, FBRX Soars On Vitiligo Data, TRAX On Watch
Yahoo Finance • 11 months ago
TransCode's TTX-MC138 To Enter Phase 2a Trial As Part Of Quantum Leap PRE-I-SPY Platform
Yahoo Finance • last year
Sector Update: Health Care Stocks Advance Late Afternoon
About
CEO | Dr. Philippe P. Calais Ph.D., Pharm., Pharm.D. |
Address | 6 Liberty Square, Boston, MA, United States, 02109 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 12 |